Search
for
Sort by
Research 541–570 of 1000+
- Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
- Mental Health as Assessed by the Symptom Checklist 90 (SCL-90) Scores in Women with and Without Polycystic Ovary Syndrome
- The Effects of FemmeBalance Supplement on Symptoms of Premenstrual Syndrome: A Four-Cycle Single-Arm Observational Study of a Novel Nutritional Supplement
- Prevalence, Symptomatology and Herbal Management of Polycystic Ovarian Syndrome
- Evaluation of dihydrotestosterone levels and total testosterone to dihydrotestosterone ratio with clinical symptoms and metabolic parameters in patients with polycystic ovary syndrome
- Polycystic Ovary Syndrome (PCOS): Causes, Symptoms, Diagnosis & Treatments
- Comparison of the Effect of Auriculotherapy, a Herbal Compound (Aslagh Capsule), and Metformin on the Clinical Symptoms of Polycystic Ovary Syndrome: Randomized Clinical Trial
- Efficacy of two traditionally used potentized homeopathic medicines, Calcarea carbonica and Lycopodium clavatum, used for treating PCOS patients: I. Effects on certain important external guiding symptoms
- Effects of supplementation with two probiotic strains (Lactobacillus helveticus and Bifidobacterium longum) on hormonal status, oxidative stress, and clinical symptoms in women with polycystic ovary syndrome: a randomized clinical trial
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Diagnosis and Management of Polycystic Ovary Syndrome (PCOS)
- Reconsidering the Polycystic Ovary Syndrome (PCOS)
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Skin lesions in polycystic ovary syndrome
- In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
- No. 350-Hirsutism: Evaluation and Treatment
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- [Disorder of hair growth in hyperprolactinemia].
- The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review
- Sexual Dysfunction in Polycystic Ovary Syndrome (PCOS): A Biopsychosocial Approach to Assessment and Management
- Association of Acne Tarda with Endocrinological Disorders
- SAT-240 Type B Insulin Resistance Resulting in Hyperthecosis in a Postmenopausal Woman
- Inositol and FSH: A new frontier for the androgenetic alopecia treatment
- The pathogenesis and treatment of polycystic ovary syndrome: What’s new?
- Editorial: Androgen-dependent diseases and their treatment
- Molecular Aspects of Polycystic Ovarian Syndrome in Female Population in Karnataka at the Southwestern Region of India
- Hirsutism among Women Attending Al-Yarmouk Teaching Hospital, (Clinical and Investigative Study)
- Serum Prolactin Levels in Adult Females with Telogen Effluvium: A Case Control Study